A potential novel therapeutic target in diabetic retinopathy: a chemokine receptor (CCR2/CCR5) inhibitor reduces retinal vascular leakage in an animal model
Finny Monickaraj, Sreenivasa Rao Oruganti, Paul McGuire, Arup Das
Topics & Concepts
CCR2Chemokine receptorDiabetic retinopathyRetinalMedicineChemokineReceptorPharmacologyOphthalmologyDiabetes mellitusInternal medicineEndocrinologyRetinal Diseases and TreatmentsOcular Diseases and Behçet’s SyndromeRetinal Imaging and Analysis